Australia - engleză - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: hyprolose; calcium silicate; amaranth aluminium lake; titanium dioxide; polyvinyl acetate phthalate; diethyl phthalate; stearic acid; purified talc; povidone; hypromellose; magnesium stearate; macrogol 6000; indigo carmine aluminium lake; citric acid monohydrate - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate, quantity: 200 mg - tablet, enteric coated - excipient ingredients: citric acid monohydrate; polyvinyl acetate phthalate; indigo carmine aluminium lake; hyprolose; magnesium stearate; povidone; stearic acid; amaranth aluminium lake; diethyl phthalate; purified talc; macrogol 6000; calcium silicate; hypromellose; titanium dioxide - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate.

Malta - engleză - Medicines Authority

wockhardt uk limited - valproate sodium - solution for infusion or injection - valproate sodium 100 mg/ml - antiepileptics

Malta - engleză - Medicines Authority

wockhardt uk limited - valproate sodium - solution for infusion or injection - valproate sodium 100 mg - antiepileptics

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

max health limited - sodium valproate 100 mg/ml - solution for injection - 100 mg/ml - active: sodium valproate 100 mg/ml excipient: dibasic sodium phosphate dodecahydrate monobasic sodium phosphate dihydrate phosphoric acid sodium hydroxide water for injection - the treatment of patients with epilepsy or bipolar disorder, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

Malta - engleză - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - valproate sodium - solution for infusion or injection - valproate sodium 100 mg - antiepileptics

Malta - engleză - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - valproate sodium - solution for infusion or injection - valproate sodium 100 mg/ml - antiepileptics

Australia - engleză - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate, quantity: 400 mg - injection, powder for - excipient ingredients: - epilim iv is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

Regatul Unit - engleză - myHealthbox

noridem enterprises ltd - sodium valproate - powder and solvent for solution for injection/infusion - 400mg - anti-epileptics; fatty acid derivatives - the treatment of epileptic patients who would normally be maintained on oral sodium valproate and for whom oral therapy is temporarily not possible.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: triethyl citrate; citric acid; magnesium stearate; sodium starch glycollate; purified talc; povidone; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin; polysorbate 80; purified water; methacrylic acid copolymer; sodium lauryl sulfate; indigo carmine; sunset yellow fcf; allura red ac; macrogol 3350 - epilepsy. primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.. mania. for the treatment of mania where other therapy has proved inadequate or is inappropriate.